SCHEMBL5376744

SCHEMBL5376744

CCc1ccc(S(=O)(=O)N(c2ccc(OC(F)(F)F)cc2)c2ccc3ocnc3c2)cc1C(=O)OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
PKM P14618 1/20 0.38
TRPM8 Q7Z2W7 3/20 0.37
HCRTR2 O43614 1/20 0.36
TSHR P16473 1/20 0.35
NAMPT P43490 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
TP53 P04637 2/20 0.34
MAPT P10636 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5368704 0.92 TRPM8 (0.41) ALDH1A1KDM4EPKMTRPM8HCRTR2
SCHEMBL5376782 0.91 GAA (0.36) ALDH1A1PKMTSHRSMN1; SMN2TP53
SCHEMBL5382107 0.90 SMN1; SMN2 (0.35) ALDH1A1KDM4EPKMTRPM8HCRTR2
SCHEMBL5373225 0.88 TP53 (0.36) ALDH1A1HCRTR2TSHRSMN1; SMN2TP53
SCHEMBL5378588 0.88 TRPM8 (0.38) ALDH1A1KDM4EPKMTRPM8HCRTR2
SCHEMBL5371938 0.84 TRPM8 (0.39) TRPM8HCRTR2SERPINE1
SCHEMBL5378792 0.82 TRPM8 (0.43) ALDH1A1KDM4EPKMTRPM8HCRTR2
SCHEMBL5368411 0.81 RXRA (0.39) ALDH1A1TRPM8SMN1; SMN2HDAC3HDAC11
SCHEMBL5367888 0.80 GAA (0.37) ALDH1A1KDM4EPKMTSHRSMN1; SMN2
SCHEMBL5391241 0.78 ALDH1A1 (0.35) ALDH1A1TRPM8HCRTR2SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALDH1A1 2956/4885KDM4E 3834/4885PKM 861/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD ALDH1A1 2752/4885KDM4E 3815/4885PKM 859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.